| Symbol | PHAR |
|---|---|
| Name | PHARMING GROUP NV |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | - |
| Address | 2333 Netherlands Neils Bohrweg 11-13 |
| Telephone | +31 715247400 |
| Fax | — |
| — | |
| Website | http://www.pharming.com |
| Incorporation | NL |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Euronext Amsterdam |
| CIK | 0001828316 |
| Description | Pharming Group is engaged in the development of products for the treatment of unmet medical needs. Additional info from NASDAQ: |
Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Read morePharming Group N.V. (PHAR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Read moreSecurities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Read morePHAR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Pharming Group (PHAR)
Read more